Dawid Maciorowski

Broad Institute — United States

Medicine · Health Sciences

7h-index261citations20works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(13), COVID-19 Clinical Research Studies(7), Computational Drug Discovery Methods(5), Virus-based gene therapy research(4), COVID-19 epidemiological studies(3)

Publications20 total

Boost and Increased Antibody Breadth Following a Second Dose of PARVAX for SARS-CoV-2 in Mice and Nonhuman Primates
Vaccines·2024Open Access
NEW GENERATION OF VACCINE TECHNOLOGIES
Wiadomości Lekarskie·2024Open Access
Immunogenicity of an AAV-Based COVID-19 Vaccine in Murine Models of Obesity and Aging
Viruses·2022· 5 citedOpen Access
Testing-Related and Geo-Demographic Indicators Strongly Predict COVID-19 Deaths in the United States during March of 2020.
PubMed·2021· 2 citedOpen Access
Environmental factors and their role in the transmission of SARS-CoV-2
Biosafety and Health·2021· 9 citedOpen Access
An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates
Cell Host & Microbe·2021· 80 citedOpen Access
Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy
International Journal of Biological Macromolecules·2021· 37 citedOpen Access
Advancing oncolytic virus therapy by understanding the biology
Nature Reviews Clinical Oncology·2021· 35 cited
Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays
Methods·2021· 38 citedOpen Access
Immunogenicity of Two AAV-Based COVID-19 Vaccine Candidates in Mouse Models of Aging and Obesity
Molecular Therapy·2021
Candidate Selection in BALB/c Mice towards a Single Dose AAV-Based COVID19 Prophylactic Vaccine
Molecular Therapy·2021
Therapeutic and Vaccine Options for COVID-19: Status after Six Months of the Disease Outbreak
SLAS DISCOVERY·2020· 7 citedOpen Access
Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening and in vitro assays
2020· 3 citedOpen Access
A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19
SLAS DISCOVERY·2020· 35 citedOpen Access
Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening and in vitro assays
2020· 2 citedOpen Access
<strong>Revealing SARS-CoV-2 Functional Druggability Through Multi-Target Cadd Screening of Repurposable Drugs</strong>
Preprints.org·2020· 3 citedOpen Access
Ribosome Display for the Generation and Selection of a Panel of Pan-Filovirus Single-Chain Antibodies as Diagnostics
Loyola eCommons (Loyola University of Chicago)·2020
Design and Synthesis of 2-aminocyclobutanone SARS-CoV-2 ligands as potential antivirals to treat COVID-19
2020
Molecular Insights into Severe Acute Respiratory Syndrome Coronavirus 2 Pathobiology: Dissecting the Interplay between Cellular Innate Immunity and Immune Evasion
Critical Reviews in Immunology·2020· 5 cited
Using the Human Microbiome as a Model for Antibiotic Efficacy
Loyola eCommons (Loyola University of Chicago)·2020Open Access

Frequent Co-authors

Prakasha Kempaiah(9), Yash Gupta(8), Ravi Durvasula(7), Nerea Zabaleta(5), Urja Bhatt(5), Reynette Estelien(5), Cheikh Tacko Diop(5), Luk H. Vandenberghe(5), David J. Ilc(5), Daniel P. Becker(5), Samantha E. Zak(4), Raman Mathur(4), Catherine M. Pearce(4), Hamza Husein(4), Ajay Bharti(4), Brijesh Rathi(4), John M. Dye(4), Wenlong Dai(3), Allison Cucalon(3), A. Sheridan(3)